NuVasive (NUVA -2.5%) underperforms after a court filing discloses Medtronic (MDT +2.7%) is...
NuVasive (NUVA -2.5%) underperforms after a court filing discloses Medtronic (MDT +2.7%) is seeking a permanent ban on NuVasive spinal surgery devices that infringe on Medtronic's IP. NuVasive tumbled in September following an adverse court ruling in its patent dispute with Medtronic.
From other sites
Video at CNBC.com (Jul 13, 2016)
Video at CNBC.com (Jun 3, 2016)
at CNBC.com (Oct 4, 2012)
at CNBC.com (Oct 3, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs